APMD Apnimed, Inc.

Fundamentals / CIK 0001745648 / USD

Apnimed, Inc. reported $371.5M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open APMD in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for APMD.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Revenue $2.48M $12.08M -- $8.80M $17.11M --
Research & Development $11.81M $9.90M -- $9.75M $15.97M --
Total Operating Expenses $34.69M $23.78M -- $17.79M $23.05M --
Operating Income -$32.20M -$11.70M -- -$8.98M -$5.94M --
Income Before Tax -$29.52M $126.1M -- -$8.72M -$5.63M --
Income Tax Expense -- $0 -- -- $0 --
Net Income -$29.52M $125.9M $67.72M -$10.91M -$69.47M -$28.65M
Basic EPS -$1.05 -- -- -$2.29 -- --
Diluted EPS -$1.05 -- -- -$2.29 -- --
Basic Shares Outstanding 28.0M 4.8M -- 4.8M 4.8M --
Diluted Shares Outstanding 28.0M 32.4M -- 4.8M 4.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for APMD.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2025-12-31
Cash & Cash Equivalents $351.8M $172.8M $41.89M
Cash & Short-Term Investments $351.8M $172.8M $41.89M
Accounts Receivable, Net $588K $690K $959K
Total Current Assets $361.0M $184.8M $45.05M
Property, Plant & Equipment, Net $46K $53K $66K
Other Non-Current Assets $24K $24K $24K
Total Non-Current Assets $10.53M $10.68M $27.82M
Total Assets $371.5M $195.5M $72.87M
Accounts Payable $4.33M $6.60M $1.79M
Deferred Revenue (Current) $17.30M $19.53M $97.81M
Total Current Liabilities $36.96M $35.58M $110.9M
Long-Term Debt $39.06M $40.27M $0
Deferred Revenue (Non-Current) $0 $0 $15.24M
Total Non-Current Liabilities $49.77M $90.12M $113.6M
Total Liabilities $86.73M $125.7M $224.5M
Total Debt (incl. Leases) $39.75M $41.02M $873K
Common Stock $1.0K $1.0K $1.0K
Retained Earnings -$233.2M -$203.7M -$397.3M
Total Stockholders' Equity $284.8M -$176.2M -$372.8M
Total Equity $284.8M -$176.2M -$372.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for APMD.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$29.52M $125.9M $67.72M -$10.91M -$69.47M -$28.65M
Stock-Based Compensation $6.27M -- -- $1.23M -- --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for APMD.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 9.77x 5.19x -- -- -- --
Quick Ratio 9.53x 4.88x -- -- -- --
Debt to Equity 0.14x -- -- -- -- --
Revenue Growth (YoY) -71.8% -29.4% -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001745648) · from March 31, 2025 Data through September 30, 2026 · synced Nov 20, 2026, 05:34 UTC · Open in terminal